BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,860,426 | -31.0% | 41,352 | +1.0% | 0.01% | -40.0% |
| Q3 2022 | $2,697,000 | -8.1% | 40,927 | -29.6% | 0.02% | 0.0% |
| Q2 2022 | $2,936,000 | +27.0% | 58,132 | +121.3% | 0.02% | -6.2% |
| Q2 2021 | $2,311,000 | +21.4% | 26,268 | +34.2% | 0.02% | +14.3% |
| Q1 2021 | $1,903,000 | -85.9% | 19,575 | -83.7% | 0.01% | -87.6% |
| Q4 2020 | $13,470,000 | +727.9% | 120,104 | +584.4% | 0.11% | +707.1% |
| Q3 2020 | $1,627,000 | +525.8% | 17,550 | +294.0% | 0.01% | +100.0% |
| Q1 2020 | $260,000 | -74.8% | 4,454 | -65.4% | 0.01% | -65.0% |
| Q4 2019 | $1,032,000 | -53.3% | 12,882 | -45.1% | 0.02% | -67.2% |
| Q2 2019 | $2,212,000 | +37.3% | 23,450 | -26.3% | 0.06% | +52.5% |
| Q2 2017 | $1,611,000 | – | 31,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |